B2M and gastric cancer: Sasaki et al. [55] have further confirmed the relative expression of intact B2m-associated HLA-E and B2m-free HCs of HLA-I during gastric cancer progression using an “HLA-E monospecific mAb” TFL-033 and an “HLA-I polyreactive mAb” MEM-E/02, respectively.